Who is sponsoring NCT04319185?

NCT04319185 is sponsored by Satellite Healthcare.

What drugs are being tested in NCT04319185?

Interventions in NCT04319185: Assistance to perform Peritoneal Dialysis (PD) at home.

What condition does NCT04319185 study?

NCT04319185 studies End Stage Kidney Disease, End Stage Renal Disease.

Is NCT04319185 still recruiting?

NCT04319185 is currently status unknown. Last updated 22 September 2021.

Last reviewed 2021-09-22 · How we verify

NCT04319185

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assisted Peritoneal Dialysis: A Feasibility Study

Status unknown NA Last updated 22 September 2021

What this trial tests

NA trial testing Assistance to perform Peritoneal Dialysis (PD) at home in End Stage Kidney Disease in 20 participants. Status unknown.

Timeline

11 September 2020

Primary endpoint
30 November 2021

31 December 2021

Quick facts

Lead sponsor	Satellite Healthcare
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	20
Start date	11 September 2020
Primary completion	30 November 2021
Estimated completion	31 December 2021
Sites	6 locations across United States

Drugs / interventions tested

Assistance to perform Peritoneal Dialysis (PD) at home

Conditions studied

End Stage Kidney Disease — all drugs for End Stage Kidney Disease →
End Stage Renal Disease — all drugs for End Stage Renal Disease →

Sponsor

Satellite Healthcare — full company profile →

Who can join

18 and older, any sex, with End Stage Kidney Disease or End Stage Renal Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with End-Stage Kidney Disease (ESKD) wishing to choose Peritoneal Dialysis (PD) may not be able to perform this modality due to advanced age, physical function/dexterity, vision, cognition, mobility, or psychosocial issues. This intervention will seek to test the feasibility of a clinical support model to address these barriers. Patients identified by their nephrologist as wishing to choose Peritoneal Dialysis (PD), but needing assistance, are referred to the research staff for discussion and consent. Based on the assessment of the subject's nephrologist, PD staff, and researchers, the subject will receive assistance beyond the standard PD care offered in US dialysis centers. Such assistance will be provided for up to one visit/day, seven days/week, for up to three months. At the end of that time period, the subject will be able to perform PD independently, have identified a care provider, or have planned with his/her nephrologist for an alternative dialysis modality.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Implementation of a Staff-Assisted Peritoneal Dialysis Program in the United States: A Feasibility Study.
Hussein WF, Bennett PN, Bennett PN, Anwaar A, et al · · 2022 · cited 16× · PMID 35383044 · DOI 10.2215/cjn.00940122
Description and outcomes of a staff-assisted peritoneal dialysis program in the United States.
Hussein WF, Chen S, Bennett PN, Atwal J, et al · · 2025 · cited 1× · PMID 38881397 · DOI 10.1177/08968608241259607

Verify or expand the search:

Other recruiting trials for End Stage Kidney Disease

Currently open trials in the same condition.

NCT06356168 — Virtual Reality in End Stage Kidney Disease · NA · recruiting
NCT05715814 — meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis · Phase 3 · recruiting
NCT05642364 — Virtual Reality in Hemodialysis to Improve Psychological Well-being · NA · active not recruiting
NCT05642156 — Hemodynamics in Chronic Hemodialysis Patients Undergoing Isolated Ultrafiltration Compared to Conventional Hemodialysis · NA · recruiting
NCT05311956 — Pain Reduction Using NEurostimulation Study · NA · active not recruiting

Other Satellite Healthcare trials

Trials by the same sponsor.

NCT05400720 — Peer Support In Dialysis · NA · completed
NCT05011136 — Physician Reimbursement Home Patients · completed
NCT05022225 — Psychosocial Reasons for Transfer to In Center Hemodialysis in Home Dialysis Patients- A Focus Group Study · completed
NCT04988568 — Experience of Patients Starting Hemodialysis · completed
NCT04806126 — Evaluation of a Virtual Home Dialysis Mentoring Program (Home) · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04319185 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Satellite Healthcare
Last refreshed: 22 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04319185.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing